Early Changes in OCT Biomarkers After the First Intravitreal Anti-VEGF Injection in Treatment-naïve DME

Enrolling by invitationOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

January 16, 2026

Study Completion Date

January 16, 2026

Conditions

Early OCT Biomarker Changes in Response to Anti-VEGF

Interventions

PROCEDURE

intravitreal injection of anti-VEGF

Ranibizumab is injected into the vitreous under aseptic conditions as part of routine DME treatment

Trial Locations (1)

Sohag University, Sohag

All Listed Sponsors

lead

Sohag University

OTHER